Adenosine receptor modulation: Potential implications in veterinary medicine

Veterinary Journal

Volumn 179, Issue 1, 2009, Pages 38-49

  Dip, Ramiro G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adenosine; Adenosine receptors; Chronic airway inflammation; Signal transduction; Veterinary inflammatory conditions

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 AMINO 4 (4 HYDROXYPHENYL) 6 (1H IMIDAZOL 2 YLMETHYLSULFANYL)PYRIDINE 3,5 DICARBONITRILE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 3 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)BICYCLO[2.2.2]OCTAN 1 YL]PROPIONIC ACID; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N CYCLOPENTYLADENOSINE; 8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CGH 2473; ENDOTOXIN; G PROTEIN COUPLED RECEPTOR; LUF 5835; METHYLXANTHINE DERIVATIVE; N [4 (3,4 DICHLOROPHENYL) 5 PYRIDIN 4 YL THIAZOL 2 YL]ACETAMIDE; REGADENOSON; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ASTHMA; CAT; CENTRAL NERVOUS SYSTEM; DRUG MEGADOSE; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOTOXEMIA; HEART ARRHYTHMIA; HEART INFARCTION; HORSE; HUMAN; IMMUNOMODULATION; KIDNEY DISEASE; LUNG INJURY; NONHUMAN; PROTEIN TARGETING; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TRANSCRIPTION INITIATION; VASODILATATION; VETERINARY MEDICINE;

ADENOSINE; ANIMALS; ASTHMA; BRONCHOCONSTRICTION; CAT DISEASES; CATS; HORSE DISEASES; HORSES; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EQUIDAE; FELIDAE;

EID: 56849093380     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.08.005     Document Type: Review

References (101)

1. Adcock I.M. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Archives for Chest Disease 52 (1997) 178-186
2. Ainsworth D.M., Appleton J.A., Antczak D.F., Santiago M.A., and Aviza G. IgG antibody responses to an inhaled antigen in horses with "heaves" (recurrent airway obstruction). Veterinary Immunology and Immunopathology 84 (2002) 169
3. Ainsworth D.M., Grunig G., Matychak M.B., Young J., Wagner B., Erb H.N., and Antczak D.F. Recurrent airway obstruction (RAO) in horses is characterised by IFN-[gamma] and IL-8 production in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology 96 (2003) 83
4. Ali S., Mustafa S.J., and Metzger W.J. Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. The Journal of Pharmacology and Experimental Therapeutics 268 (1994) 1328-1334
5. Arch J.R., and Newsholme E.A. The control of the metabolism and the hormonal role of adenosine. Essays in Biochemistry 14 (1978) 82-123
6. Atkinson J.J., and Senior R.M. Matrix metalloproteinase-9 in lung remodeling. American Journal of Respiratory Cell and Molecular Biology 28 (2003) 12-24
7. Auchampach J.A., Jin X., Wan T.C., Caughey G.H., and Linden J. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Molecular Pharmacology 52 (1997) 846-860
8. Auchampach J.A., Ge Z.D., Wan T.C., Moore J., and Gross G.J. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. American Journal of Physiology: Heart and Circulatory Physiology 285 (2003) H607-H613
9. Auchampach J.A., Jin X., Moore J., Wan T.C., Kreckler L.M., Ge Z.D., Narayanan J., Whalley E., Kiesman W., Ticho B., Smits G., and Gross G.J. Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anaesthetised dogs. Journal of Pharmacology and Experimental Therapeutics 308 (2004) 846-856
10. Beukers M.W., Chang L.C., von Frijtag Drabbe Kunzel J.K., Mulder-Krieger T., Spanjersberg R.F., Brussee J., and Ap I.J. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine. Journal of Medicinal Chemistry 47 (2004) 3707-3709
11. Bivalacqua T.J., Champion H.C., Lambert D.G., and Kadowitz P.J. Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 (2002) R1696-R1709
12. Brandon C.I., Vandenplas M., Dookwah H., Linden J., and Murray T.F. Cloning and pharmacological characterization of the equine adenosine A2A receptor: a potential therapeutic target for the treatment of equine endotoxemia. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 243-253
13. Brandon C.I., Vandenplas M., Dookwah H., and Murray T.F. Cloning and pharmacological characterization of the equine adenosine A3 receptor. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 255-263
14. Buber T., Saragusty J., Ranen E., Epstein A., Bdolah-Abram T., and Bruchim Y. Evaluation of lidocaine treatment and risk factors for death associated with gastric dilatation and volvulus in dogs: 112 cases (1997-2005). Journal of the American Veterinary Medical Association 230 (2007) 1334-1339
15. Bureau F., Delhalle S., Bonizzi G., Fievez L., Dogne S., Kirschvink N., Vanderplasschen A., Merville M.P., Bours V., and Lekeux P. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. Journal of Immunology 165 (2000) 5822-5830
16. Chou C.C., and Vickroy T.W. Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues. American Journal of Veterinary Research 64 (2003) 216-224
17. Church M.K., Palo G.J., and Holgate S.T. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. Journal of Immunology 129 (1982) 2116-2121
18. Couetil L.L., Art T., de Moffarts B., Becker M., Melotte D., Jaspar F., Bureau F., and Lekeux P. DNA binding activity of transcription factors in bronchial cells of horses with recurrent airway obstruction. Veterinary Immunology and Immunopathology 113 (2006) 11-20
19. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. Journal of Applied Physiology 76 (1994) 5-13
20. Cushley M.J., Tattersfield A.E., and Holgate S.T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. British Journal of Clinical Pharmacology 15 (1983) 161-165
21. Cushley M.J., Tallant N., and Holgate S.T. The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. European Journal of Respiratory Diseases 67 (1985) 185-192
22. Day Y.J., Marshall M.A., Huang L., McDuffie M.J., Okusa M.D., and Linden J. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. American Journal of Physiology: Gastrointestinal and Liver Physiology 286 (2004) G285-G293
23. Day Y.J., Li Y., Rieger J.M., Ramos S.I., Okusa M.D., and Linden J. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. Journal of Immunology 174 (2005) 5040-5046
24. Debrue M., Hamilton E., Joubert P., Lajoie-Kadoch S., and Lavoie J.P. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology 105 (2005) 25-31
25. Demoly P., Chanez P., Pujol J.L., Gauthier-Rouviere C., Michel F.B., Godard P., and Bousquet J. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respiratory Medicine 89 (1995) 329-335
26. Derksen F.J., Robinson N.E., Armstrong P.J., Stick J.A., and Slocombe R.F. Airway reactivity in ponies with recurrent airway obstruction (heaves). Journal of Applied Physiology 58 (1985) 598-604
27. Di Stefano A., Caramori G., Oates T., Capelli A., Lusuardi M., Gnemmi I., Ioli F., Chung K.F., Donner C.F., Barnes P.J., and Adcock I.M. Increased expression of nuclear factor-KB in bronchial biopsies from smokers and patients with COPD. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 20 (2002) 556-563
28. Donoso M.V., Lopez R., Miranda R., Briones R., and Huidobro-Toro J.P. A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. American Journal of Physiology: Heart and Circulatory Physiology 288 (2005) H2439-H2449
29. Driver A.G., Kukoly C.A., Ali S., and Mustafa S.J. Adenosine in bronchoalveolar lavage fluid in asthma. The American Review of Respiratory Disease 148 (1993) 91-97
30. Elliott J., and Brady F.E. Characterization of vasodilatory adenosine receptors in equine digital veins. Journal of Veterinary Pharmacology and Therapeutics 21 (1998) 74-81
31. Eder C., Crameri R., Mayer C., Eicher R., Straub R., Gerber H., Lazary S., and Marti E. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Veterinary Immunology and Immunopathology 73 (2000) 241
32. Ernens I., Rouy D., Velot E., Devaux Y., and Wagner D.R. Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway. Circulation Research 99 (2006) 590-597
33. Ezeamuzie C.I., and Philips E. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. British Journal of Pharmacology 127 (1999) 188-194
34. Feoktistov I., and Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. Journal of Clinical Investigation 96 (1995) 1979-1986
35. Feoktistov I., Garland E.M., Goldstein A.E., Zeng D., Belardinelli L., Wells J.N., and Biaggioni I. Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Biochemical Pharmacology 62 (2001) 1163-1173
36. Fishman P., Bar-Yehuda S., Madi L., Rath-Wolfson L., Ochaion A., Cohen S., and Baharav E. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Research & Therapy 8 (2006) R33
37. Forsythe P., McGarvey L.P., Heaney L.G., MacMahon J., and Ennis M. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clinical Science (London) 96 (1999) 349-355
38. Fozard J.R., Ellis K.M., Villela Dantas M.F., Tigani B., and Mazzoni L. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. European Journal of Pharmacology 438 (2002) 183-188
39. Fozard J.R., Baur F., and Wolber C. Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog. European Journal of Pharmacology 475 (2003) 79-84
40. Franchini M., Gilli U., Akens M.K., Fellenberg R.V., and Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Veterinary Immunology and Immunopathology 66 (1998) 53-65
41. Gao Z., Chen T., Weber M.J., and Linden J. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. Journal of Biological Chemistry 274 (1999) 5972-5980
42. Gao Z.-g., and Jacobson K.A. 2-Chloro-N6-cyclopentyladenosine, adenosine A1 receptor agonist, antagonises the adenosine A3 receptor. European Journal of Pharmacology 443 (2002) 39
43. Gessi S., Varani K., Merighi S., Cattabriga E., Iannotta V., Leung E., Baraldi P.G., and Borea P.A. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Molecular Pharmacology 61 (2002) 415-424
44. Giguere S., Viel L., Lee E., MacKay R.J., Hernandez J., and Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology 85 (2002) 147
45. Glover D.K., Ruiz M., Takehana K., Petruzella F.D., Rieger J.M., Macdonald T.L., Watson D.D., Linden J., and Beller G.A. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. American Journal of Physiology: Heart and Circulatory Physiology 288 (2007) H1851-H1858
46. Hart L.A., Krishnan V.L., Adcock I.M., Barnes P.J., and Chung K.F. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. American Journal of Respiratory and Critical Care Medicine 158 (1998) 1585-1592
47. Hasko G., Xu D.Z., Lu Q., Nemeth Z.H., Jabush J., Berezina T.L., Zaets S.B., Csoka B., and Deitch E.A. Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock. Critical Care Medicine 34 (2006) 1119-1125
48. Hirt R.A., Vondrakova K., de Arespacochaga A.G., Gutl A., and van den Hoven R. Effects of cadmium chloride inhalation on airflow limitation to histamine, carbachol and adenosine 5′-monophosphate assessed by barometric whole body plethysmography in healthy dogs. The Veterinary Journal 173 (2007) 62
49. Holgate S.T., Lewis R.A., and Austen K.F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proceedings of the National Academy of Science of the United States of America 77 (1980) 6800-6804
50. Huszar E., Vass G., Vizi E., Csoma Z., Barat E., Molnar Vilagos G., Herjavecz I., and Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 20 (2002) 1393-1398
51. Iwatsuki K. Subtypes of adenosine receptors on pancreatic exocrine secretion in anaesthetised dogs. Fundamental & Clinical Pharmacology 14 (2000) 203-208
52. Kaufmann I., Hoelzl A., Schliephake F., Hummel T., Chouker A., Lysenko L., Peter K., and Thiel M. Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock 27 (2007) 25-31
53. 2A agonists and antagonists. Journal of Medicinal Chemistry 46 (2003) 4847-4859
54. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., and Gustin P. Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation. The Veterinary Journal 174 3 (2007) 541-553
55. Kobayashi T., Mizumoto H., and Karasawa A. Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, in conscious dogs. Biological & Pharmaceutical Bulletin 16 (1993) 1231-1235
56. Koos B.J., Kawasaki Y., Kim Y.H., and Bohorquez F. Adenosine A2A-receptor blockade abolishes the roll-off respiratory response to hypoxia in awake lambs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 (2005) R1185-R1194
57. Lappas C.M., Day Y.J., Marshall M.A., Engelhard V.H., and Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. Journal of Experimental Medicine 203 (2006) 2639-2648
58. Lavoie J.-P., Maghni K., Desnoyers M., Taha R., Martin J.G., and Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterised by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine 164 (2001) 1410-1413
59. Leckie M.J., Bryan S.A., Hansel T.T., and Barnes P.J. Novel therapy for COPD. Expert Opinion on Investigational Drugs 9 (2000) 3-23
60. Lee H.T., Xu H., Nasr S.H., Schnermann J., and Emala C.W. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. American Journal of Physiology: Renal Physiology 286 (2004) F298-F306
61. Li F.Z., Kimura S., Nishiyama A., Rahman M., Zhang G.X., and Abe Y. Ischemic preconditioning protects post-ischemic renal function in anesthetised dogs: role of adenosine and adenine nucleotides. Acta Pharmacologica Sinica 26 (2005) 851-859
62. Lohse M.J., Klotz K.N., Lindenborn-Fotinos J., Reddington M., Schwabe U., and Olsson R.A. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) - a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 336 (1987) 204-210
63. Lukashev D., Ohta A., Apasov S., Chen J.F., and Sitkovsky M. Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. Journal of Immunology 173 (2004) 21-24
64. McGorum B.C., Dixon P.M., and Halliwell R.E. Quantification of histamine in plasma and pulmonary fluids from horses with chronic obstructive pulmonary disease, before and after 'natural (hay and straw) challenges'. Veterinary Immunology and Immunopathology 36 (1993) 223-237
65. Madi L., Cohen S., Ochayin A., Bar-Yehuda S., Barer F., and Fishman P. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. Journal of Rheumatology 34 (2007) 20-26
66. Moro S., Gao Z.G., Jacobson K.A., and Spalluto G. Progress in the pursuit of therapeutic adenosine receptor antagonists. Medicinal Research Reviews 26 (2006) 131-159
67. Morrow J.D., and Roberts L.J. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. American Journal of Respiratory and Critical Care Medicine 166 (2002) S25-S30
68. Neely C.F., and Keith I.M. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. American Journal of Physiology: Lung Cellular and Molecular Physiology 268 (1995) L1036-L1046
69. Neely C.F., and Matot I. Pharmacological probes for A1 and A2 adenosine receptors in vivo in feline pulmonary vascular bed. American Journal of Physiology 270 (1996) H610-H619
70. Neely C.F., Jin J., and Keith I.M. A1-adenosine receptor antagonists block endotoxin-induced lung injury. American Journal of Physiology: Lung Cellular and Molecular Physiology 272 (1997) L353-L361
71. Nemeth Z.H., Leibovich S.J., Deitch E.A., Vizi E.S., Szabo C., and Hasko G. cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine. The Journal of Pharmacology and Experimental Therapeutics 306 (2003) 1042-1049
72. Nguyen C., Teo J.L., Matsuda A., Eguchi M., Chi E.Y., Henderson Jr. W.R., and Kahn M. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proceedings of the National Academy of Science of the United States of America 100 (2003) 1169-1173
73. Norris A.A., and Eyre P. Reactivity of equine tracheal smooth muscle to adenosine and some phosphorylated derivatives. Journal of Veterinary Pharmacology and Therapeutics 5 (1982) 199-201
74. Norris Reinero C.R., Decile K.C., Berghaus R.D., Williams K.J., Leutenegger C.M., Walby W.F., Schelegle E.S., Hyde D.M., and Gershwin L.J. An experimental model of allergic asthma in cats sensitised to house dust mite or Bermuda grass allergen. International Archives of Allergy and Immunology 135 (2004) 117-131
75. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
76. Padrid P.A., Mitchell R.W., Ndukwu I.M., Spaethe S., Shiue P., Cozzi P., Leff A.R., and Shiou P. Cyproheptadine-induced attenuation of type-I immediate-hypersensitivity reactions of airway smooth muscle from immune-sensitised cats. American Journal of Veterinary Research 56 (1995) 109-115
77. Padrid P. Feline asthma. Diagnosis and treatment. The Veterinary clinics of North America. Small Animal Practice 30 (2000) 1279-1293
78. Poucher S.M., Keddie J.R., Brooks R., Shaw G.R., and McKillop D. Pharmacodynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog. The Journal of Pharmacy and Pharmacology 48 (1996) 601-606
79. Rath-Wolfson L., Bar-Yehuda S., Madi L., Ochaion A., Cohen S., Zabutti A., and Fishman P. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clinical and Experimental Rheumatology 24 (2006) 400-406
80. Rivo J., Zeira E., Galun E., and Matot I. Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis. American Journal of Transplantation 4 (2004) 1941-1948
81. Robinson N.E., Derksen F.J., Olszewski M.A., and Buechner-Maxwell V.A. The pathogenesis of chronic obstructive pulmonary disease of horses. British Veterinary Journal 152 (1996) 283-306
82. Rush B.R., Flaminio M.J., Matson C.J., Hakala J.E., and Shuman W. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. American Journal of Veterinary Research 59 (1998) 1033-1038
83. Ryzhov S., Goldstein A.E., Matafonov A., Zeng D., Biaggioni I., and Feoktistov I. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. Journal of Immunology 172 (2004) 7726-7733
84. Ryzhov S., Goldstein A.E., Biaggioni I., and Feoktistov I. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Molecular Pharmacology 70 (2006) 727-735
85. Salvatore C.A., Jacobson M.A., Taylor H.E., Linden J., and Johnson R.G. Molecular cloning and characterization of the human A3 adenosine receptor. Proceedings of the National Academy of Science of the United States of America 90 (1993) 10365-10369
86. Shim J.O., Shin C.Y., Lee T.S., Yang S.J., An J.Y., Song H.J., Kim T.H., Huh I.H., and Sohn U.D. Signal transduction mechanism via adenosine A1 receptor in the cat esophageal smooth muscle cells. Cellular Signaling 14 (2002) 365-372
87. Spicuzza L., and Polosa R. The role of adenosine as a novel bronchoprovocant in asthma. Current Opinion in Allergy and Clinical Immunology 3 (2003) 65-69
88. Sun C.X., Young H.W., Molina J.G., Volmer J.B., Schnermann J., and Blackburn M.R. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. Journal of Clinical Investigation 115 (2005) 35-43
89. Sun D., Samuelson L.C., Yang T., Huang Y., Paliege A., Saunders T., Briggs J., and Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proceedings of the National Academy of Science of the United States of America 98 (2001) 9983-9988
90. Tan-Allen K.Y., Sun X.C., and Bonanno J.A. Characterization of adenosine receptors in bovine corneal endothelium. Experimental Eye Research 80 (2005) 687-696
91. Thorn J.A., and Jarvis S.M. Adenosine transporters. General Pharmacology 27 (1996) 613-620
92. Trams E.G., and Brown E.A. The activity of 2′,3′-cyclic adenosine monophosphate 3′-phosphoesterhydrolase in elasmobranch and teleost brain. Comparative Biochemistry and Physiology: B, Comparative Biochemistry 48 (1974) 185-189
93. Tsoumakidou M., Tzanakis N., Kyriakou D., Chrysofakis G., and Siafakas N.M. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma. Clinical & Experimental Allergy 34 (2004) 234-240
94. Vallon V., Muhlbauer B., and Osswald H. Adenosine and Kidney Function. Physiological Reviews 86 (2006) 901-940
95. Van Belle H., Goossens F., and Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. American Journal of Physiology 252 (1987) H886-H893
96. Wright K.N. Assessment and treatment of supraventricular tachyarrhythmias. In: Bonagura J.D. (Ed). Kirk's Current Veterinary Therapy XIII, Small Animal Practice (2000), WB Saunders, Philadelphia, PA, USA 726-730
97. Yang H., Avila M.Y., Peterson-Yantorno K., Coca-Prados M., Stone R.A., Jacobson K.A., and Civan M.M. The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure. Current Eye Research 30 (2005) 747-754
98. Zablocki J.A., Wu L., Shryock J., and Belardinelli L. Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF). Current Topics in Medicinal Chemistry 4 (2004) 839-854
99. Zhao G., Linke A., Xu X., Ochoa M., Belloni F., Belardinelli L., and Hintze T.H. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. The Journal of Pharmacology and Experimental Therapeutics 307 (2003) 182-189
100. Zhong H., Shlykov S.G., Molina J.G., Sanborn B.M., Jacobson M.A., Tilley S.L., and Blackburn M.R. Activation of murine lung mast cells by the adenosine A3 receptor. Journal of Immunology 171 (2003) 338-345
101. Zhou Q.Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., and Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proceedings of the National Academy of Science of the United States of America 89 (1992) 7432-7436